Detalles de la búsqueda
1.
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
Breast Cancer Res Treat
; 201(2): 151-159, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338729
2.
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study.
Future Oncol
; 18(35): 3913-3927, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36537885
3.
Trajectories of alcohol consumption during life and the risk of developing breast cancer.
Br J Cancer
; 125(8): 1168-1176, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34483338
4.
Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.
Lancet Oncol
; 21(5): 645-654, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32224306
5.
Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07).
Eur J Cancer Care (Engl)
; 29(4): e13253, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32578279
6.
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study.
Breast Cancer Res Treat
; 177(1): 115-125, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152327
7.
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.
Br J Cancer
; 119(12): 1464-1470, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30467411
8.
Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.
Oncologist
; 22(11): 1301-1308, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28701571
9.
Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trial.
Eur Respir J
; 50(1)2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28679605
10.
Physical activity and breast cancer risk by pathological subtype.
Gynecol Oncol
; 144(3): 577-585, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28057355
11.
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis.
Lancet Oncol
; 17(10): 1386-1395, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27575023
12.
Quality Indicators to Assure and Improve Cancer Care in Spain Using the Delphi Technique.
J Natl Compr Canc Netw
; 14(5): 553-8, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27160233
13.
Noninvasive ventilation for severely acidotic patients in respiratory intermediate care units : Precision medicine in intermediate care units.
BMC Pulm Med
; 16(1): 97, 2016 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27387544
14.
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Clin Transl Oncol
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578537
15.
Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis.
Breast Cancer Res
; 15(6): R105, 2013 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-24192331
16.
Adjuvant docetaxel for high-risk, node-negative breast cancer.
N Engl J Med
; 363(23): 2200-10, 2010 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-21121833
17.
Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial.
J Neuromuscul Dis
; 10(4): 627-637, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212068
18.
CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2- Metastatic Breast Cancer.
Clin Cancer Res
; 29(8): 1557-1568, 2023 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36749874
19.
Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients.
Clin Cancer Res
; 29(20): 4166-4177, 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37490393
20.
Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.
Cancer
; 118(1): 241-7, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21717449